Improving the clinical risk score: An analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases-Reference-Cited by-同舟云学术

Improving the clinical risk score: An analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases

Published:2012-02 Issue:2 Volume:151 Page:162-170
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Maithel Shishir K.,Gönen Mithat,Ito Hiromichi,DeMatteo Ronald P.,Allen Peter J.,Fong Yuman,Blumgart Leslie H.,Jarnagin William R.,D'Angelica Michael I.

Publisher

Elsevier BV

Subject

Surgery

Reference24 articles.

1. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial;Portier;J Clin Oncol,2006

2. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases;Abdalla;Ann Surg,2004

3. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer;Goldberg;J Clin Oncol,2004

4. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study;Tournigand;J Clin Oncol,2004

5. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy;Shirota;J Clin Oncol,2001

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers;Frontiers in Oncology;2023-10-27

2. A Comprehensive Prognostic Model for Colorectal Cancer Liver Metastasis Recurrence After Neoadjuvant Chemotherapy;Frontiers in Oncology;2022-06-16

3. Chemo-sensitizing agents from natural origin for colorectal cancer: Pharmacodynamic and cellular pharmacokinetics approaches;Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies;2020

4. Molecular Biomarkers for the Management of Colorectal Cancer Liver Metastases;Colorectal Cancer Liver Metastases;2019-12-29

5. Thymidylate synthase: a predictive biomarker in resected colorectal liver metastases receiving 5-FU treatment;Future Oncology;2018-02